Advisory Board and Editors Diabetes & Endocrinology

Arti Ahluwalia

Associate Prof. of Bioengineering, University of Pisa, Head of In-Vitro Models Group and NanoBioscopy Lab at the National Council of Research Institute of Clinical Physiology (CNR-IFC). Also involved in capacity building in the field of Biomedical Engineering, in association with UNECA and FABLAB Pisa .Author of over 100 peer-reviewed publications and of several patents on microfabrication and on bioreactors, co-founder of 2 high-tech companies.

George E Bentley

Professor of Integrative Biology and Neuroscience.
Director, UC Berkeley Field Station for the Study of Behavior, Ecology and Reproduction. Editorial Board of Domestic Animal Endocrinology, Frontiers in Systems and Integrative Pharmacology, Frontiers in Endocrinology

Jeffrey A. Bluestone

A.W. and Mary Margaret Clausen Distinguished Professor and Director, Hormone Research Institute. Serves on the Science Translational Medicine advisory board and founding Director, Immune Tolerance Network. A recipient of a Guggenheim Fellowship and elected member of the Academy of Arts and Sciences and National Academy of Medicine. Dr. Bluestone has spent over 35 years working as an immunologist interested in immune tolerance as it relates to autoimmunity and organ transplantation.

Nichole Carlson

Associate Professor Biostatistics and Informatics Colorado School of Public Health; Associate Chair for Research Biostatistics and Informatics; Director Colorado Biostatistics Consortium; Director Clinical and Translational Science Institute Biostatistics, Epidemiology and Research Design Program; Theme Chair, Biostatistics Special Interest Group, Association for Clinical and Translational Science

George P. Chrousos

Prof. George P Chrousos is internationally recognized for his research on the glucocorticoid signaling system of the cell, on the diseases of the hypothalamic-pituitary-adrenal axis, and on the physiological and molecular mechanisms of stress. He is one of the 250 most cited scientists internationally (ISI highly cited) included not only in the list of Clinical Medicine, but also in that of Biology and Biochemistry, and the highest cited clinical endocrinologist and pediatrician in the world.

José G B Derraik

Dr José Derraik was born in Rio de Janeiro (Brazil), but moved to New Zealand in 1995. José has a very broad academic background, with a BSc and MSc in Ecology from the University of Otago (New Zealand), and a PhD in Public Health (University of Otago). His MSc examined invertebrate biodiversity in human-modified habitats. His PhD focused on vector ecology, more precisely on mosquitoes in New Zealand and how the threat of a mosquito-borne disease outbreak has been affected by ongoing anthropogenic environmental change. José then worked as a Senior Advisor for MAF Biosecurity NZ, where he provided expert advice to the NZ government on biosecurity threats to human health.

In 2008, José joined the Liggins Institute (University of Auckland) where he has been working on paediatric research, as well as on a number of clinical trials in adolescents and adults at risk of metabolic disease. His research focuses primarily on the long-term effects of early life events (such as preterm or post-term birth) in childhood. However, José has recently been appointed as an honorary research associate at Uppsala University in Sweden, where alongside his Swedish colleagues he has been examining also the long-term effects of early life events in adulthood.

Lastly, José is currently involved in a large multi-institutional project (A Better Start) in New Zealand, with a leading role in a number of studies aiming to predict, prevent, and mitigate childhood obesity in the country.

Daniela P Foti

Graduated in Medicine and Surgery at the University of Catania, Italy, specialist in Endocrinology and in Internal Medicine, PhD in Endocrinological and Metabolic Sciences. Professor of Clinical Pathology, University "Magna Græcia" of Catanzaro, Italy.

Dr. Foti has conducted significant studies and research in the field of endocrine at the Clinical Endocrinology Branch of NIH, Bethesda, USA from 1986 to 1987 and at Thyroid Molecular Biology Laboratory at the University of California San Francisco from 1987 to 1989. For more than ten years, her primary scientific interest is studying the pathophysiology of insulin action. She is the author of more than 80 scientific publications. Dr. Foti is a member of the Italian Society of Laboratory Medicine (SIMeL) and the Italian Society of Endocrinology (SIE).

Jason M.R. Gill

Professor of Cardio-metabolic Health in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow. Lead an active multi-disciplinary research group investigating the effects of exercise and diet on the prevention and management of vascular and metabolic diseases from the molecular to the whole-body level. Major research interests include: why certain population groups appear to be particularly susceptible to the adverse effects of a ‘Westernised’ lifestyle, and how lifestyle interventions can modulate this excess risk; the interactions between physical activity, energy balance, body fatness and disease risk; and the mechanisms by which exercise regulates lipoprotein metabolism. Member of the NICE guidelines update committee for prevention of type 2 diabetes, and was member of development groups for the Scottish Intercollegiate Guidelines Network (SIGN) guidelines for the prevention and treatment of obesity and for prevention of cardiovascular disease. Past Chair of the British Association of Sport and Exercise Sciences (BASES) Division of Physical Activity for Health and Fellow of BASES. Director of the MSc programme in Sport and Exercise Science & Medicine at the University of Glasgow.

Gwyn W Gould

Gwyn is Professor of Cell Biology at the University of Glasgow where he has held a group leader position since 1989. He did his undergraduate and postgraduate work at the University of Southampton, studying lipid/protein interactions under the supervision of Tony Lee for his PhD. This was followed by postdoctoral work at Dartmouth Medical School where his interest in membrane trafficking began. His research focusses upon the control of glucose transport by insulin in adipocytes, muscle and cardiac tissue.

Wolfgang F Graier

Previously the Chair of the Institute of Molecular Biology and Biochemistry, Medical University of Graz, Austria.

Expertise in Vascular Cell Biology, Intracellular Ion Mesaurements (e.g. Ca2+), Organelle Function (Mitochondria, ER), Live-cell Imaging, Confocal microscopy, Electrophysiology, Cell Physiology, Development of Biosensors, Signal Transduction,
Cell Biology, Energy metabolism, Aging.

Scott M. Grundy

Director of the Center for Human Nutrition. Member of the American Society for Clinical Investigation, the American Association of Physicians, and the National Academies of Sciences (Institute of Medicine).

Dr. Grundy's major research area is in cholesterol and lipoprotein metabolism. He has published over 400 original papers, and numerous solicited articles and chapters. Notable research accomplishments include the development of methods for measuring cholesterol balance and biliary lipid secretion in humans, identifying the metabolic causes of cholesterol gallstones, defining effects of saturated and unsaturated fats, especially monounsaturated fatty acids, on cholesterol and lipoprotein metabolism, uncovering genetic defects underlying hypercholesterolemia and other forms of dyslipidemia, identifying metabolic defects in hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia, and defining mechanisms of action of several lipid-lowering drugs, notably fibrates and HMG CoA reductase inhibitors (statins).